Bridging the Gap from Successful Trials to Global Scale-Up
Yogan A. Patel
Chris Denning
As part of our ‘Going Global’ series, MHA Baker Tilly is pleased to announce a webinar that will be of interest to a wide range of life science and MedTech companies who wish to accelerate their growth on an international stage.
Chaired by MHA Baker Tilly’s Head of Life Sciences, Yogan Patel, we will be joined by a panel of experts to discuss business and resource planning, balancing the needs of clinical trials with investor expectations, working with Key Opinion Leaders and finalising the economic case for funders including the NHS and specialist insurers. Along the way we anticipate answering the many questions that arise in the journey to commercialisation, including optimising your product launch model and strategy, tax planning, managing stakeholders from key staff to investors and how best to deal with ongoing regulatory compliance.
Who will benefit from attendance?
If you are a CEO, a director or a manager tasked with scaling up a life science or MedTech company, there will be valuable advice and commentaries for you.
This webinar will be delivered in a question-and-answer format and represents an excellent opportunity to hear direct ‘first-hand’ experience from practitioners as well as answer your questions. Please click on the link below to register and you can also pose questions in advance or on the day.
Agenda:
- Regulatory preparation with MHRA, EMA and the FDA
- Managing investors’ expectations
- Data collection and analysis and how best to present this to non-clinical stakeholders.
- Pre-launch funding rounds to finance commercialisation
- Discussions with NHS or insurers for reimbursement and funding models
- Tax planning, varying pricing and profitability to market in different geographical locations
Speakers/Participants
-
Partner
Yogan A. Patel Partner -
Partner
Chris Denning Corporate and International Tax Partner
-
Renos Savva Head of Innovation and Venture Development at Discovery Park
Renos is the inventor (1999) of the Combinatorial Domain Hunting technology that launched Domainex (which he co-founded 2001), now a successful Cambridge ecosystem CRO, as a start-up. Since spinning that company out of his then academic research lab, Renos developed and convened the postgraduate program Bio-business at the University of London and inspired and mentored many graduate students from the LIDo and MRC-DTP (at UCL and Birkbeck) who followed their own start-up star.
-
Mario Prohasky Director, Baker Tilly US
Director, Baker Tilly US Mario Prohasky is a director with Baker Tilly’s digital solutions practice. He is an experienced risk management professional and advisory services leader focused on the unique challenges of the life sciences industry. With a strong emphasis on the global risk, compliance and commercial operations challenges of the life sciences industry.
-
Nicholas Stern Board NED and CFO
Nick acts as a CFO, NED, advisor and mentor to many start-ups and scale-up businesses, especially those in the life science and tech sectors where he brings ‘real-world’ commercial expertise to bear on project work. He also advises businesses on restructuring, corporate finance and fundraising. Nick has a commercial mindset and is used to working beyond the confines of finance, with experience in operational and strategic development matters.
